Elliptic Laboratories AS (EIP) Ratios
Elliptic Laboratories AS Ratios
DE:EIP's free cash flow for Q2 2026 was $-13.76M. For the 2026 fiscal year, DE:EIP's free cash flow was decreased by $-5.25M and operating cash flow was $-8.51M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.61 | 7.83 | 7.45 | 13.13 | 14.67 |
| Quick Ratio | 5.61 | 7.83 | 7.45 | 13.13 | 14.67 |
| Cash Ratio | 1.83 | 3.06 | 4.64 | 10.37 | 12.08 |
| Solvency Ratio | -3.60 | 0.43 | -0.51 | -0.91 | -0.30 |
| Operating Cash Flow Ratio | 0.34 | -0.42 | -1.83 | -0.74 | -0.60 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -5.30 | -11.38 | -3.19 | -2.71 |
| Net Current Asset Value | $ 100.31M | $ 159.77M | $ 142.84M | $ 201.92M | $ 236.36M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.05 | 0.07 | 0.04 | 0.05 |
| Debt-to-Equity Ratio | 0.11 | 0.06 | 0.08 | 0.04 | 0.05 |
| Debt-to-Capital Ratio | 0.10 | 0.06 | 0.08 | 0.04 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.04 | 0.00 | 0.01 | 0.02 | 0.03 |
| Financial Leverage Ratio | 1.17 | 1.11 | 1.14 | 1.07 | 1.08 |
| Debt Service Coverage Ratio | -49.95 | 4.02 | -4.81 | -3.05 | -1.36 |
| Interest Coverage Ratio | -23.98 | 1.98 | -20.49 | -15.63 | -7.67 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest Debt Per Share | 0.22 | 0.21 | 0.27 | 0.15 | 0.19 |
| Net Debt to EBITDA | 0.86 | -2.22 | 2.25 | 6.19 | 21.64 |
| Profitability Margins | |||||
| Gross Profit Margin | -4.80% | 33.40% | -17.90% | -20.63% | 6.94% |
| EBIT Margin | -49.78% | 14.73% | -65.74% | -73.12% | -21.79% |
| EBITDA Margin | -24.78% | 19.47% | -58.24% | -51.38% | -17.01% |
| Operating Profit Margin | -49.78% | 3.57% | -72.81% | -80.92% | -20.40% |
| Pretax Profit Margin | -59.26% | 12.92% | -68.58% | -75.49% | -23.98% |
| Net Profit Margin | -138.16% | 6.79% | -55.62% | -63.38% | -20.54% |
| Continuous Operations Profit Margin | -138.16% | 6.79% | -55.62% | -63.38% | -20.54% |
| Net Income Per EBT | 233.15% | 52.56% | 81.10% | 83.96% | 85.66% |
| EBT Per EBIT | 119.04% | 361.93% | 94.20% | 93.29% | 117.52% |
| Return on Assets (ROA) | -63.14% | 2.48% | -10.91% | -9.45% | -3.02% |
| Return on Equity (ROE) | -73.74% | 2.75% | -12.44% | -10.13% | -3.27% |
| Return on Capital Employed (ROCE) | -25.46% | 1.40% | -15.39% | -12.68% | -3.15% |
| Return on Invested Capital (ROIC) | -24.85% | 0.72% | -12.18% | -10.46% | -2.65% |
| Return on Tangible Assets | -93.18% | 3.04% | -12.99% | -10.94% | -3.35% |
| Earnings Yield | -19.69% | 0.81% | -2.11% | -1.44% | -0.41% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.16 | 1.12 | 1.13 | 1.29 | 1.88 |
| Payables Turnover | 53.01 | 67.53 | 20.90 | 37.65 | 16.77 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 8.16 | 7.92 | 3.43 | 23.08 | 19.57 |
| Asset Turnover | 0.46 | 0.37 | 0.20 | 0.15 | 0.15 |
| Working Capital Turnover Ratio | 0.73 | 0.80 | 0.37 | 0.23 | 0.31 |
| Cash Conversion Cycle | 309.10 | 319.77 | 306.35 | 274.21 | 172.28 |
| Days of Sales Outstanding | 315.98 | 325.18 | 323.82 | 283.91 | 194.04 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 6.89 | 5.40 | 17.47 | 9.69 | 21.76 |
| Operating Cycle | 315.98 | 325.18 | 323.82 | 283.91 | 194.04 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.08 | -0.10 | -0.43 | -0.12 | -0.11 |
| Free Cash Flow Per Share | 0.08 | -0.39 | -0.67 | -0.35 | -0.29 |
| Dividend Paid and CapEx Coverage Ratio | 255.74 | -0.35 | -1.78 | -0.55 | -0.61 |
| Capital Expenditure Coverage Ratio | 255.74 | -0.35 | -1.78 | -0.55 | -0.61 |
| Operating Cash Flow Coverage Ratio | 0.37 | -0.55 | -1.76 | -1.00 | -0.63 |
| Operating Cash Flow to Sales Ratio | 0.08 | -0.08 | -0.67 | -0.25 | -0.20 |
| Free Cash Flow Yield | 1.11% | -3.73% | -3.94% | -1.57% | -1.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.14 | 122.86 | -47.47 | -69.47 | -243.32 |
| Price-to-Sales (P/S) Ratio | 7.02 | 8.35 | 26.41 | 44.03 | 49.98 |
| Price-to-Book (P/B) Ratio | 3.74 | 3.39 | 5.91 | 7.04 | 7.96 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 90.00 | -26.79 | -25.37 | -63.53 | -95.97 |
| Price-to-Operating Cash Flow Ratio | 89.65 | -103.84 | -39.64 | -179.69 | -252.13 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.99 | -3.80 | -0.36 | 11.35 |
| Enterprise Value Multiple | -27.45 | 40.66 | -43.08 | -79.51 | -272.13 |
| Enterprise Value | 689.07M | 1.04B | 1.71B | 2.13B | 2.53B |
| EV to EBITDA | -27.45 | 40.66 | -43.08 | -79.51 | -272.13 |
| EV to Sales | 6.80 | 7.92 | 25.09 | 40.86 | 46.29 |
| EV to Free Cash Flow | 87.26 | -25.41 | -24.10 | -58.94 | -88.90 |
| EV to Operating Cash Flow | 86.92 | -98.46 | -37.67 | -166.72 | -233.56 |
| Tangible Book Value Per Share | 1.13 | 2.47 | 2.36 | 2.67 | 3.11 |
| Shareholders’ Equity Per Share | 1.81 | 3.10 | 2.88 | 3.13 | 3.49 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -1.33 | 0.47 | 0.19 | 0.16 | 0.14 |
| Revenue Per Share | 0.97 | 1.26 | 0.65 | 0.50 | 0.56 |
| Net Income Per Share | -1.34 | 0.09 | -0.36 | -0.32 | -0.11 |
| Tax Burden | 2.33 | 0.53 | 0.81 | 0.84 | 0.86 |
| Interest Burden | 1.19 | 0.88 | 1.04 | 1.03 | 1.10 |
| Research & Development to Revenue | 0.18 | 0.20 | 0.31 | 0.16 | 0.10 |
| SG&A to Revenue | 0.13 | 0.10 | 0.12 | 0.11 | 0.10 |
| Stock-Based Compensation to Revenue | 0.03 | 0.04 | 0.14 | 0.24 | 0.19 |
| Income Quality | -0.13 | -1.18 | 1.20 | 0.32 | 0.83 |
Currency in NOK